Skin Conditions: Lichen Planus, Erythema Multiforme, Psoriasis, Ringworm, and Tinea Versicolor

Lichen Planus: A skin condition that affects cutaneous and mucosal surfaces, characterised by flat-topped plaques and papules with a purple hue and white striae. It can be treated with topical steroids and immunomodulators.

Erythema Multiforme: A skin condition characterised by targetoid lesions with a central depression, usually starting on the acral extensor surfaces and progressing to involve the trunk and back. It can be caused by medications, infections, or underlying conditions.

Psoriasis: An autoimmune chronic skin condition presenting with erythematous plaques and greyscale on the extensor surfaces of extremities. It is not associated with intra-oral mucosal lesions.

Ringworm: A fungal skin infection characterised by erythematous, scaly patches on the skin surface of the trunk, back, and extremities. It can lead to the formation of pustules or vesicles.

Tinea Versicolor: A fungal skin infection characterised by pale or dark, copper-coloured patches on the arms, neck, and trunk. It does not involve mucosal surfaces.

Understanding Different Skin Conditions

The medication lithium has been known to worsen psoriasis in some patients and can even cause psoriasis in those who did not previously have it, even at normal therapeutic levels. It is important to inform both the patient and their psychiatrist of this potential effect. Furosemide, on the other hand, does not typically worsen or cause drug-induced psoriasis, but can lead to electrolyte imbalances. Amiodarone also does not worsen or cause drug-induced psoriasis, but can cause a bluish discoloration of the skin.

Psoriasis can be worsened by various factors. These include physical trauma, consumption of alcohol, and certain medications such as beta blockers, lithium, antimalarials (chloroquine and hydroxychloroquine), NSAIDs and ACE inhibitors, and infliximab. Additionally, stopping the use of systemic steroids can also exacerbate psoriasis. It is important to note that streptococcal infection can trigger guttate psoriasis, a type of psoriasis characterized by small, drop-like lesions on the skin. Therefore, individuals with psoriasis should be aware of these exacerbating factors and take necessary precautions to manage their condition.

When it comes to managing scalp psoriasis, the approach is slightly different from managing plaque psoriasis. The first-line treatment typically involves using potent corticosteroids topically. Among the options, betamethasone valerate is the best answer as it is a potent corticosteroid that can be prescribed as a shampoo or mousse for easier application. For severe and extensive psoriasis, oral methotrexate may be recommended, but this is not applicable to the patient in question. Phototherapy is also an option for extensive psoriasis, but not for this patient who has well-controlled chronic plaque psoriasis. If no improvement is seen after 8 weeks of using a topical potent corticosteroid, second-line treatment may involve using topical vitamin D.

NICE recommends a step-wise approach for chronic plaque psoriasis, starting with regular emollients and then using a potent corticosteroid and vitamin D analogue separately, followed by a vitamin D analogue twice daily, and then a potent corticosteroid or coal tar preparation if there is no improvement. Phototherapy, systemic therapy, and topical treatments are also options for management. Topical steroids should be used cautiously and vitamin D analogues may be used long-term. Dithranol and coal tar have adverse effects but can be effective.

Common Skin Lesions and Cancers: Characteristics and Clinical Presentations

Squamous cell carcinoma (SCC), actinic keratosis, Bowen’s disease, cold sores, and leukoplakia are common skin lesions and cancers that have distinct characteristics and clinical presentations.

SCC is a malignant tumour that commonly affects the backs of the hands and forearms, the upper part of the face, and the lower lip and pinna in men. The first clinical sign is induration, which may take on nodular, plaque-like, verrucous, or ulcerated characteristics. The limits of induration are not sharp and usually extend beyond the visible margins of the lesion. The surrounding tissue is often inflamed. SCCs rarely metastasize.

Actinic keratosis is a sun-induced scaly or hyperkeratotic lesion that has the potential to become malignant. It is characterized by multifocal, scaly, hyperpigmented or scaly lesions, usually brown with a scaly base, occurring on the head, neck, forearms, and hands.

Bowen’s disease is an intraepidermal (in situ) squamous cell carcinoma that arises in sun-exposed sites, especially the lower legs in women. It is characterized by well-defined pink and scaly patches or plaques that may become crusty, fissured, or ulcerated as lesions grow.

Cold sores are recurrent infections of orofacial herpes simplex that present as grouped vesicles, especially of the lips and perioral skin. The eruption is often preceded by a tingling, itching, or burning sensation. Over a few days, the vesicles form a crust, and the eruption resolves within 7–10 days.

Leukoplakia is a white patch or plaque of the oral mucosa that cannot be characterized clinically or pathologically as any other condition.

A non-healing lesion is also of concern, especially in patients with a history of smoking and advanced age, as it may indicate a malignant cause. Early detection and treatment are crucial in preventing the progression of these skin lesions and cancers.

Treatment Regime for Moderately Severe Eczema with Superimposed Infection

Moderately severe eczema with evidence of superimposed infection requires a specific treatment regime. The severity of eczema is categorized into four categories: clear, mild, moderate, and severe. In this case, the patient has small areas of dry skin mainly in the flexures, and there is evidence of superimposed infection with the erythematous, weeping patch of skin in the lateral thigh, indicating infected eczema/cellulitis.

The treatment regime should include a regular emollient ointment, such as Diprobase®, applied generously to the skin multiple times a day. Additionally, a moderately potent topical corticosteroid, such as betamethasone valerate 0.025% or clobetasone butyrate 0.05%, should be used sparingly on the inflamed areas once a day. The patient must be advised to apply the steroid first and allow 15–20 min for it to be absorbed before applying the emollient. Treatment should last 7–14 days and should continue until 48 h after the eczematous patches have cleared.

Furthermore, oral antibiotics are necessary for the treatment of infected eczema. Oral flucloxacillin is considered first-line, and treatment usually lasts for a 10-day period.

It is important to note that hydrocortisone 1% cream is only a mild steroid and not indicated in the initial management of moderate eczema. Betamethasone valerate 1% cream is a potent topical corticosteroid and should be reserved for the management of acute flare-ups of severe eczema. Oral flucloxacillin alone is not sufficient for treatment, and there is a need for a moderately potent topical corticosteroid as well to settle the inflammation.

In conclusion, a combination of regular emollient ointment, moderately potent topical corticosteroid, and oral antibiotics is necessary for the effective treatment of moderately severe eczema with superimposed infection.

It’s a challenging question, especially since the decision on psoriasis treatment often involves the patient and doctor’s preference. While vitamin D analogues can be an option, calcipotriol is not advisable due to its potential to cause irritation. Instead, calcitriol and tacalcitol can be considered. For facial psoriasis, mild potency topical steroids can be effective. However, coal tar may not be well-tolerated for facial application due to its unpleasant odor and messiness.

NICE recommends a step-wise approach for chronic plaque psoriasis, starting with regular emollients and then using a potent corticosteroid and vitamin D analogue separately, followed by a vitamin D analogue twice daily, and then a potent corticosteroid or coal tar preparation if there is no improvement. Phototherapy, systemic therapy, and topical treatments are also options for management. Topical steroids should be used cautiously and vitamin D analogues may be used long-term. Dithranol and coal tar have adverse effects but can be effective.

Compression bandaging is recommended for the management of venous ulceration, as the ankle-brachial pressure index readings suggest that the ulcers are caused by venous insufficiency rather than arterial issues.

Venous Ulceration and its Management

Venous ulceration is a type of ulcer that is commonly seen above the medial malleolus. To assess for poor arterial flow that could impair healing, an ankle-brachial pressure index (ABPI) is important in non-healing ulcers. A normal ABPI is usually between 0.9 – 1.2, while values below 0.9 indicate arterial disease. Interestingly, values above 1.3 may also indicate arterial disease, particularly in diabetics, due to false-negative results caused by arterial calcification.

The only treatment that has been shown to be of real benefit for venous ulceration is compression bandaging, usually four-layer. Oral pentoxifylline, a peripheral vasodilator, can also improve the healing rate. There is some small evidence supporting the use of flavonoids, but little evidence to suggest benefit from hydrocolloid dressings, topical growth factors, ultrasound therapy, and intermittent pneumatic compression. Proper management of venous ulceration is crucial to promote healing and prevent complications.

Management of Lichen Planus: Topical Clobetasone Butyrate

Lichen planus is a skin condition that can be managed with daily potent topical steroids, such as clobetasone butyrate. As the lesions improve, the potency of the steroid can be decreased. It is important to advise patients to only treat the active, itchy lesions and not the post-inflammatory hyperpigmentation to minimize side effects. These treatments can also be used on the genital skin and scalp. Sedating antihistamines may help with itching at night, but should only be used periodically. Emollients and oral antihistamines are not first-line treatments for lichen planus. Referring for a punch biopsy is not necessary unless the presentation is atypical. The characteristic histological findings of lichen planus include irregular acanthosis of the epidermis, irregular thickening of the granular layer, and compact hyperkeratosis in the center of the papule. Topical clotrimazole and dapsone are not first-line treatments for lichen planus.

The initial approach to treating acne involves the use of a topical retinoid (such as tretinoin, isotretinoin, or adapalene) or benzoyl peroxide, particularly if there are papules and pustules present. Patients should be informed of the potential side effects of topical retinoids, which may include burning, redness, and dryness of the skin, as well as eye irritation and swelling. However, topical retinoids are not associated with aggravating acne, causing headaches or nausea, or leading to yellowing of the skin.

Acne vulgaris is a common skin condition that typically affects adolescents, with the face, neck, and upper trunk being the most commonly affected areas. It is characterized by the obstruction of hair follicles with keratin plugs, leading to the formation of comedones, inflammation, and pustules. The severity of acne can be classified as mild, moderate, or severe, depending on the presence and extent of inflammatory lesions, papules, and pustules.

The management of acne vulgaris typically involves a step-up approach, starting with single topical therapy such as topical retinoids or benzoyl peroxide. If this is not effective, topical combination therapy may be used, which includes a topical antibiotic, benzoyl peroxide, and topical retinoid. Oral antibiotics such as tetracyclines may also be prescribed, but they should be avoided in pregnant or breastfeeding women and children under 12 years of age. Erythromycin may be used in pregnancy, while minocycline is now considered less appropriate due to the possibility of irreversible pigmentation. Oral antibiotics should be used for a maximum of three months and always co-prescribed with a topical retinoid or benzoyl peroxide to reduce the risk of antibiotic resistance.

Combined oral contraceptives (COCP) are an alternative to oral antibiotics in women, and Dianette (co-cyrindiol) may be used as it has anti-androgen properties. However, it has an increased risk of venous thromboembolism compared to other COCPs, so it should generally be used second-line and for only three months. Oral isotretinoin is a potent medication that should only be used under specialist supervision, and it is contraindicated in pregnancy. Finally, there is no evidence to support dietary modification in the management of acne vulgaris.

Skin type 1 according to the Fitzpatrick classification is characterized by pale skin with features like blue eyes, red hair, and freckles. Individuals with this skin type always experience burning and never tanning. The classification system ranges from type 1, which is most prone to burning, to type 6, which is Afro-Caribbean skin that never burns.

Skin type is a crucial factor in determining the risk of developing skin cancer. The Fitzpatrick classification system is commonly used to categorize skin types based on their response to UV radiation. This system divides skin types into six categories, ranging from those who always burn and never tan to those who never burn and always tan.

Type I skin is the most sensitive to UV radiation and is characterized by red hair, freckles, and blue eyes. These individuals never tan and always burn when exposed to the sun. Type II skin usually tans but always burns, while Type III skin always tans but may sometimes burn. Type IV skin always tans and rarely burns, and Type V skin burns and tans after extreme UV exposure. Finally, Type VI skin, which is common in individuals of African descent, never tans and never burns.

Understanding your skin type is essential in protecting yourself from skin cancer. Those with fair skin, such as Type I and II, are at a higher risk of developing skin cancer and should take extra precautions when exposed to the sun. On the other hand, those with darker skin, such as Type V and VI, may have a lower risk of skin cancer but should still take measures to protect their skin from UV radiation. By knowing your skin type and taking appropriate precautions, you can reduce your risk of developing skin cancer.